Keith Katkin
SNDXKeith Katkin serves as Director at Syndax Pharmaceuticals, Inc. (SNDX). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.
Keith Katkin's Insider Trading at Syndax Pharmaceuticals, Inc. (SNDX)
Buys
1 · $91.1K
Sells
0 · $0.00
Total Shares Bought
10,000
Total Shares Sold
0
Keith Katkin's Insider Trading at Emergent BioSolutions Inc. (EBS)
Buys
0 · $0.00
Sells
1 · $49.4K
Total Shares Bought
0
Total Shares Sold
7,844
Related Insiders
Michael A Metzger
director, officer: Chief Executive Officer
SNDXSell · Feb 9, 2026
Michael A Metzger
Chief Executive Officer
SNDXSell · Feb 9, 2026
Jessica Perl
SVP, General Counsel, Corp Sec
EBSSell · Feb 9, 2026
Keith A. Goldan
Chief Financial Officer
SNDXSell · Feb 9, 2026
Keith A. Goldan
officer: Chief Financial Officer
SNDXSell · Feb 9, 2026
William Hartzel
SVP, Bioservices
EBSSell · Feb 6, 2026
Coleen Glessner
EVP, Quality & Ethics, and CPL
EBSSell · Feb 6, 2026
LINDAHL RICHARD S
EVP, Chief Financial Officer
EBSSell · Feb 6, 2026